280 related articles for article (PubMed ID: 17548623)
1. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells.
Kang HK; Liu M; Datta SK
J Immunol; 2007 Jun; 178(12):7849-58. PubMed ID: 17548623
[TBL] [Abstract][Full Text] [Related]
2. Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future).
Datta SK
Front Immunol; 2021; 12():629807. PubMed ID: 33936042
[TBL] [Abstract][Full Text] [Related]
3. Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets.
Kang HK; Michaels MA; Berner BR; Datta SK
J Immunol; 2005 Mar; 174(6):3247-55. PubMed ID: 15749855
[TBL] [Abstract][Full Text] [Related]
4. The histone peptide H4 71-94 alone is more effective than a cocktail of peptide epitopes in controlling lupus: immunoregulatory mechanisms.
Kang HK; Chiang MY; Liu M; Ecklund D; Datta SK
J Clin Immunol; 2011 Jun; 31(3):379-94. PubMed ID: 21287397
[TBL] [Abstract][Full Text] [Related]
5. Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity.
Zhang L; Bertucci AM; Ramsey-Goldman R; Harsha-Strong ER; Burt RK; Datta SK
Clin Immunol; 2013 Dec; 149(3):365-78. PubMed ID: 24211843
[TBL] [Abstract][Full Text] [Related]
6. Regulatory T cells in lupus.
Kang HK; Datta SK
Int Rev Immunol; 2006; 25(1-2):5-25. PubMed ID: 16531276
[TBL] [Abstract][Full Text] [Related]
7. Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus.
Kaliyaperumal A; Mohan C; Wu W; Datta SK
J Exp Med; 1996 Jun; 183(6):2459-69. PubMed ID: 8676066
[TBL] [Abstract][Full Text] [Related]
8. Apigenin, a non-mutagenic dietary flavonoid, suppresses lupus by inhibiting autoantigen presentation for expansion of autoreactive Th1 and Th17 cells.
Kang HK; Ecklund D; Liu M; Datta SK
Arthritis Res Ther; 2009; 11(2):R59. PubMed ID: 19405952
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells.
Kaliyaperumal A; Michaels MA; Datta SK
J Immunol; 1999 May; 162(10):5775-83. PubMed ID: 10229810
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus.
Zhang L; Bertucci AM; Ramsey-Goldman R; Burt RK; Datta SK
J Immunol; 2009 Nov; 183(10):6346-58. PubMed ID: 19841178
[TBL] [Abstract][Full Text] [Related]
12. Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor alpha chain.
Shi Y; Kaliyaperumal A; Lu L; Southwood S; Sette A; Michaels MA; Datta SK
J Exp Med; 1998 Feb; 187(3):367-78. PubMed ID: 9449717
[TBL] [Abstract][Full Text] [Related]
13. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells.
Yamazaki S; Dudziak D; Heidkamp GF; Fiorese C; Bonito AJ; Inaba K; Nussenzweig MC; Steinman RM
J Immunol; 2008 Nov; 181(10):6923-33. PubMed ID: 18981112
[TBL] [Abstract][Full Text] [Related]
14. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs.
Hackl D; Loschko J; Sparwasser T; Reindl W; Krug AB
Eur J Immunol; 2011 May; 41(5):1334-43. PubMed ID: 21469103
[TBL] [Abstract][Full Text] [Related]
15. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
Mohan C; Adams S; Stanik V; Datta SK
J Exp Med; 1993 May; 177(5):1367-81. PubMed ID: 8478612
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La/Sjögren's syndrome (SS)-B.
Pan ZJ; Horton CG; Lawrence C; Farris AD
Clin Exp Immunol; 2016 Oct; 186(1):18-29. PubMed ID: 27227559
[TBL] [Abstract][Full Text] [Related]
17. Manipulating regulatory T cells: a promising strategy to treat autoimmunity.
Zhang D; Tu E; Kasagi S; Zanvit P; Chen Q; Chen W
Immunotherapy; 2015; 7(11):1201-11. PubMed ID: 26568117
[TBL] [Abstract][Full Text] [Related]
18. Adoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis.
Yang J; Liu L; Yang Y; Kong N; Jiang X; Sun J; Xie R
J Immunol Res; 2017; 2017():7573154. PubMed ID: 28702462
[TBL] [Abstract][Full Text] [Related]
19. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
Sharabi A; Lapter S; Mozes E
J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
[TBL] [Abstract][Full Text] [Related]
20. Major peptide autoepitopes for nucleosome-centered T and B cell interaction in human and murine lupus.
Datta SK
Ann N Y Acad Sci; 2003 Apr; 987():79-90. PubMed ID: 12727626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
